Reuters Photojournalism
Our day's top images, in-depth photo essays and offbeat slices of life. See the best of Reuters photography. See more | Photo caption
Ethiopia's salt trails
For centuries merchants have traveled to Ethiopia to collect salt from the surface of the vast desert basin. Slideshow
Sponsored Links
EU agency backs Novartis' Votubia for kidney tumors
A man walks past the logo of Swiss drugmaker Novartis AG in front of a plant in Basel October 25, 2011.
Credit: Reuters/Arnd Wiegmann
ZURICH |
ZURICH (Reuters) - European regulators on Friday recommended approval of a Novartis' drug Votubia for the treatment of non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC).
The Committee for Medicinal Products for Human Use (CHMP) issued a positive recommendation for Votubia also known as evorolimus for the treatment of adult patients with renal angiomyolipoma associated with TSC.
Evorolimus is already approved in the United States under the name Afinitor for the treatment of TSC.
(Reporting by Caroline Copley)
- Tweet this
- Link this
- Share this
- Digg this
- Reprints
Follow Reuters